Switch theme
Sign up to access all valuation multiples
Blue Jet Healthcare Ltd is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare Products. The operations of the company are organized in three product categories which are contrast media intermediates, artificial sweeteners, pharma intermediates, and active pharmaceutical ingredients.
1968
447
LTM Revenue $126M
LTM EBITDA $46.4M
$1.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Blue Jet Healthcare has a last 12-month revenue (LTM) of $126M and a last 12-month EBITDA of $46.4M.
In the most recent fiscal year, Blue Jet Healthcare achieved revenue of $121M and an EBITDA of $49.7M.
Blue Jet Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Blue Jet Healthcare valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $126M | XXX | $121M | XXX | XXX | XXX |
| Gross Profit | $69.7M | XXX | $66.6M | XXX | XXX | XXX |
| Gross Margin | 55% | XXX | 55% | XXX | XXX | XXX |
| EBITDA | $46.4M | XXX | $49.7M | XXX | XXX | XXX |
| EBITDA Margin | 37% | XXX | 41% | XXX | XXX | XXX |
| EBIT | $44.2M | XXX | $42.2M | XXX | XXX | XXX |
| EBIT Margin | 35% | XXX | 35% | XXX | XXX | XXX |
| Net Profit | $37.2M | XXX | $35.7M | XXX | XXX | XXX |
| Net Margin | 29% | XXX | 30% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Blue Jet Healthcare's stock price is INR 904 (or $11).
Blue Jet Healthcare has current market cap of INR 157B (or $1.8B), and EV of INR 154B (or $1.8B).
See Blue Jet Healthcare trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.8B | $1.8B | XXX | XXX | XXX | XXX | $0.21 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Blue Jet Healthcare has market cap of $1.8B and EV of $1.8B.
Blue Jet Healthcare's trades at 16.2x EV/Revenue multiple, and 40.5x EV/EBITDA.
Equity research analysts estimate Blue Jet Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Blue Jet Healthcare has a P/E ratio of 49.4x.
See valuation multiples for Blue Jet Healthcare and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.8B | XXX | $1.8B | XXX | XXX | XXX |
| EV (current) | $1.8B | XXX | $1.8B | XXX | XXX | XXX |
| EV/Revenue | 14.3x | XXX | 16.2x | XXX | XXX | XXX |
| EV/EBITDA | 38.8x | XXX | 40.5x | XXX | XXX | XXX |
| EV/EBIT | 40.8x | XXX | 48.0x | XXX | XXX | XXX |
| EV/Gross Profit | 25.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | 49.4x | XXX | 58.1x | XXX | XXX | XXX |
| EV/FCF | -388.3x | XXX | -1739.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialBlue Jet Healthcare's last 12 month revenue growth is 27%
Blue Jet Healthcare's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Blue Jet Healthcare's rule of 40 is 67% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Blue Jet Healthcare's rule of X is 104% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Blue Jet Healthcare and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 27% | XXX | 26% | XXX | XXX | XXX |
| EBITDA Margin | 37% | XXX | 40% | XXX | XXX | XXX |
| EBITDA Growth | 28% | XXX | 22% | XXX | XXX | XXX |
| Rule of 40 | 67% | XXX | 67% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 104% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 20% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Jubilant Pharmova | XXX | XXX | XXX | XXX | XXX | XXX |
| Biocon | XXX | XXX | XXX | XXX | XXX | XXX |
| Syngene International | XXX | XXX | XXX | XXX | XXX | XXX |
| Dishman Carbogen Amics | XXX | XXX | XXX | XXX | XXX | XXX |
| Cohance Lifesciences | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Blue Jet Healthcare acquired XXX companies to date.
Last acquisition by Blue Jet Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . Blue Jet Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Blue Jet Healthcare founded? | Blue Jet Healthcare was founded in 1968. |
| Where is Blue Jet Healthcare headquartered? | Blue Jet Healthcare is headquartered in India. |
| How many employees does Blue Jet Healthcare have? | As of today, Blue Jet Healthcare has 447 employees. |
| Is Blue Jet Healthcare publicy listed? | Yes, Blue Jet Healthcare is a public company listed on BOM. |
| What is the stock symbol of Blue Jet Healthcare? | Blue Jet Healthcare trades under 544009 ticker. |
| When did Blue Jet Healthcare go public? | Blue Jet Healthcare went public in 2023. |
| Who are competitors of Blue Jet Healthcare? | Similar companies to Blue Jet Healthcare include e.g. Jubilant Pharmova, Biocon, Syngene International, Dishman Carbogen Amics. |
| What is the current market cap of Blue Jet Healthcare? | Blue Jet Healthcare's current market cap is $1.8B |
| What is the current revenue of Blue Jet Healthcare? | Blue Jet Healthcare's last 12 months revenue is $126M. |
| What is the current revenue growth of Blue Jet Healthcare? | Blue Jet Healthcare revenue growth (NTM/LTM) is 27%. |
| What is the current EV/Revenue multiple of Blue Jet Healthcare? | Current revenue multiple of Blue Jet Healthcare is 14.3x. |
| Is Blue Jet Healthcare profitable? | Yes, Blue Jet Healthcare is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Blue Jet Healthcare? | Blue Jet Healthcare's last 12 months EBITDA is $46.4M. |
| What is Blue Jet Healthcare's EBITDA margin? | Blue Jet Healthcare's last 12 months EBITDA margin is 37%. |
| What is the current EV/EBITDA multiple of Blue Jet Healthcare? | Current EBITDA multiple of Blue Jet Healthcare is 38.8x. |
| What is the current FCF of Blue Jet Healthcare? | Blue Jet Healthcare's last 12 months FCF is -$4.6M. |
| What is Blue Jet Healthcare's FCF margin? | Blue Jet Healthcare's last 12 months FCF margin is -4%. |
| What is the current EV/FCF multiple of Blue Jet Healthcare? | Current FCF multiple of Blue Jet Healthcare is -388.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
